Related Experiment Video
Updated: May 8, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Predicting higher risk factors for COVID-19 short-term reinfection in patients with rheumatic diseases: a modeling
Yao Liang1, Siwei Xie2, Xuqi Zheng1
1Department of Rheumatology and Immunology, Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Tianhe District, Guangzhou, China.
Background:
Corona virus disease 2019 (COVID-19) reinfection, particularly short-term reinfection, poses challenges to the management of rheumatic diseases and may increase adverse clinical outcomes. This study aims to develop machine learning models to predict and identify the risk of short-term COVID-19 reinfection in patients with rheumatic diseases.
Methods:
We developed four prediction models using explainable machine learning to assess the risk of short-term COVID-19 reinfection in 543 patients with rheumatic diseases. Psychological health was evaluated using the Functional Assessment of Chronic Illness Therapy Fatigue (FACIT-F) scale, the Patient Health Questionnaire-9 (PHQ-9), the Generalized Anxiety Disorder 7-item (GAD-7) questionnaire, and the Pittsburgh Sleep Quality Index (PSQI) scale. Health status and disease activity were assessed using the EuroQol-5 Dimension-3 Level (EQ-5D-3L) descriptive system and the Visual Analogue Score (VAS) scale. The model performance was assessed by Area Under the Receiver Operating Characteristic Curve (AUC), Area Under the Precision-Recall Curve (AUPRC), and the geometric mean of sensitivity and specificity (G-mean). SHapley Additive exPlanations (SHAP) analysis was used to interpret the contribution of each predictor to the model outcomes.
Results:
The eXtreme Gradient Boosting (XGBoost) model demonstrated superior performance with an AUC of 0.91 (95% CI 0.87-0.95). Significant factors of short-term reinfection included glucocorticoid taper (OR = 2.61, 95% CI 1.38-4.92), conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) taper (OR = 2.97, 95% CI 1.90-4.64), the number of symptoms (OR = 1.24, 95% CI 1.08-1.42), and GAD-7 scores (OR = 1.07, 95% CI 1.02-1.13). FACIT-F scores were associated with a lower likelihood of short-term reinfection (OR = 0.95, 95% CI 0.93-0.96). Besides, we found that the GAD-7 score was one of the most important predictors.
Conclusion:
We developed explainable machine learning models to predict the risk of short-term COVID-19 reinfection in patients with rheumatic diseases. SHAP analysis highlighted the importance of clinical and psychological factors. Factors included anxiety, fatigue, depression, poor sleep quality, high disease activity during initial infection, and the use of glucocorticoid taper were significant predictors. These findings underscore the need for targeted preventive measures in this patient population.
More Related Videos
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Steps in Outbreak Investigation
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway